Full-Time

Head of Engineering

Ultrasound Systems

Updated on 8/23/2026

iSono Health

iSono Health

11-50 employees

Portable automated 3D breast ultrasound system

Compensation Overview

$170k - $205k/yr

+ Annual bonus + Stock-based compensation

Sunnyvale, CA, USA

In Person

Master's, PhD

Category
Engineering Management (1)
Required Skills
Python
Machine Learning
MATLAB
Quality Assurance (QA)
Cybersecurity
Risk Management
C/C++

Get referred to iSono Health

See people who can refer or advise you

Requirements
  • A Master of Science or Doctor of Philosophy degree in Biomedical Engineering, Electrical Engineering, Mechanical Engineering, Physics, or a related field.
  • 8–10+ years of medical device or ultrasound product development experience, including shipped products.
  • Hands-on expertise in ultrasound systems, including transducer physics, array design, beamforming, and image reconstruction.
  • Experience with real-time signal and image processing.
  • Proficiency in Python or MATLAB for simulation, analysis, and algorithm development.
  • Experience diagnosing and resolving system-level performance issues.
  • A proven track record obtaining FDA 510(k), De Novo, or PMA clearance.
  • Strong command of design controls, ISO 13485, and ISO 14971.
  • Familiarity with IEC 62304, IEC 60601, and cybersecurity requirements for software-driven medical devices.
  • Experience with C/C++ or embedded systems.
  • Experience with automated or robotic imaging systems.
  • Experience developing AI/ML-enabled medical devices.
Responsibilities
  • Define and execute the research and development strategy aligned to commercialization goals and corporate objectives.
  • Own the technology roadmap across ultrasound hardware, artificial intelligence and machine learning, software, and future platform development.
  • Identify emerging technologies and innovation opportunities that strengthen the company’s competitive position.
  • Collaborate with the CEO on strategic planning, investor presentations, and technical due diligence.
  • Lead end-to-end product development from concept through commercialization, including hardware, firmware, transducer, and software integration.
  • Own design controls, the Design History File, risk management under ISO 14971, and verification and validation planning under 21 CFR Part 820 and ISO 13485.
  • Drive product performance, reliability, manufacturability, and usability improvements.
  • Design, prototype, and validate ultrasound system components, including transducer performance, beamforming pipelines, and acoustic signal processing.
  • Develop or significantly advance an artificial intelligence and machine learning component, such as image quality assessment, lesion detection, segmentation, or automated scan optimization.
  • Write production-quality code in Python, MATLAB, or C/C++ for signal processing, image reconstruction, or model training pipelines.
  • Run bench-level experiments, analyze results, and iterate on hands-on hardware development.
  • Diagnose and resolve system-level performance failures at the signal, image, and integration levels.
  • Author technical specifications and design documentation to FDA design control standards.
  • Set project priorities, milestones, resource allocation, and development budgets.
  • Provide technical oversight of key suppliers and subsystem vendors.
  • Partner with Regulatory Affairs and Quality to support FDA submissions and international approvals.
  • Translate clinical needs into technical product requirements and collaborate with radiologists and key opinion leaders.
  • Work with Operations and Manufacturing on product transfer and scale-up.
  • Represent the company technically in investor, partner, and customer engagements.
  • Recruit, mentor, and develop a lean, multidisciplinary research and development team.
  • Build organizational capability to support current commercialization and future product lines.
  • Foster a culture of accountability, innovation, and continuous improvement.
Desired Qualifications
  • Startup or early-stage company experience, including the ability to work across multiple functions.

Isono Health makes a portable, automated 3D breast ultrasound system called ATUSA. It lets clinicians screen and monitor breast cancer without needing a trained ultrasound operator by combining a wearable accessory, a 3D scanner, a Windows app for real-time image display, and a secure web app for remote viewing. The system standardizes and speeds up whole-breast image acquisition and analysis, reportedly delivering results 15-20 times faster than manual probing. It targets high-risk patients who need personalized, accessible monitoring and markets to hospitals, clinics, and individual healthcare providers. Revenue comes from selling the ATUSA hardware and software, with potential additional income from subscription-based remote monitoring services. Compared with traditional ultrasound options, ATUSA emphasizes automation, portability, standardized imaging, and remote data access, reducing dependence on operator expertise and enabling broader screening and follow-up.

Company Size

11-50

Company Stage

Seed

Total Funding

$6.6M

Headquarters

San Francisco, California

Founded

2014

Get referred to iSono Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The January 2026 commercial launch opened a $14 billion U.S. breast-imaging market.
  • Abdul Latif Jameel Health distribution expands access across 31 Global South markets.
  • Seed and non-dilutive funding reached $14.7 million, financing validation and sales execution.

What critics are saying

  • Breast imaging reimbursement remains uncertain; hospitals delay adoption without clear CPT economics.
  • A flawed AUDIBLE readout would stall Series A and commercial deployments by 2026.
  • Sixty percent-plus workflow change risk: radiology incumbents and GE Healthcare defend installed ultrasound budgets.

What makes iSono Health unique

  • ATUSA is FDA-cleared and wearable, eliminating sonographer dependence in breast imaging.
  • Two-minute whole-breast scans beat manual ultrasound and standardize 3D acquisition.
  • The NIH-backed AUDIBLE Study validates operator-independent imaging across UC Davis, City of Hope.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

0%

2 year growth

0%
ICE
Jan 16th, 2026
iSono Health Launches World's First Wearable, Automated, Portable, FDA-Cleared Breast Ultrasound Platform

iSono Health launches world's first wearable, automated, portable, fda-cleared breast ultrasound platform. iSono Health, a pioneer in women's health imaging, has announced the commercial launch of ATUSA, an FDA-cleared, wearable, and automated 3D quantitative breast ultrasound platform. Designed to bring high-quality imaging into everyday clinics, ATUSA unlocks the $14 billion U.S. breast imaging market by eliminating reliance on hard-to-find skilled sonographers and cost-prohibitive equipment. A graduate of Y Combinator and the Texas Medical Center Accelerator, iSono Health has gained significant industry recognition, including the HLTH 2025 Rising Star (Diagnostics) and the WISH 2024 Global Awards. Building on this commercial launch, the company is also announcing the opening of its Series A financing at its inaugural Next Horizon Summit during JPMorgan Week to accelerate global deployments and advance its AI-driven "sentient partner" roadmap toward machine-as-the-expert breast imaging robotics. Standard mammography often fails the 40 million American women with dense breast tissue, creating a massive diagnostic gap where cancers can remain hidden. It can be a painful experience and often exposes women to unnecessary X-ray radiation, leaving those of reproductive age with limited screening options. ATUSA can fundamentally change the economics and accessibility of breast health through a unique fusion of wearable hardware and cloud-based intelligence: * Automated Scanning: Utilizing a wearable, hands-free accessory, ATUSA(TM) captures full 3D volumes in approximately two minutes per breast, roughly 10x faster than manual handheld ultrasound. This ensures consistent and repeatable images are generated, regardless of the operator's skill level. * Point-of-Care Integration: The system empowers OB/GYNs and primary care providers to offer specialist-level imaging directly in their offices, generating standardized 3D whole-breast visualization directly at the point of care. * USaaS Business Model: A scalable "Ultrasound-as-a-Service" model that combines the wearable hardware, cloud-based AI, and consumables to create a recurring revenue stream while lowering the barrier to entry for local clinics. * Advanced "Sentient" AI: iSono Health is working to move beyond simple detection toward a "sentient partner" model, where the system utilizes acoustic biomarkers and machine learning to sense patient-specific needs and provide real-time diagnostic support. "ATUSA(TM) is a system-wide upgrade for women's breast health," said Neda Razavi, CEO of iSono Health. "We are putting the power of a world-class radiology suite into the hands of local clinicians, replacing slow, manual workflows with real-time diagnostic images at the point of care." A core pillar of the ATUSA launch is the initiation of the AUDIBLE Study, a pivotal multicenter clinical trial supported by a grant from the National Institutes of Health (NIH). This 800-patient study is designed to evaluate the diagnostic performance of the ATUSA(TM) platform compared to traditional mammography and MRI. * AI Products Validation: Assessing the performance of iSono's machine-learning algorithms in identifying and classifying abnormal masses. * Operator Independence: Proving that the automated, wearable hardware provides consistent, high-fidelity 3D volumes regardless of the user's clinical background. The study is being conducted at leading medical institutions, including UC Davis, Veda Trials (Axia Women's Health), and City of Hope, ensuring the technology is vetted by the nation's top oncology and radiology experts. "What we need are imaging solutions that are easy to use, require minimal training, and can be brought directly into communities," said Dr. John R. Scheel, M.D., Ph.D., M.P.H., Vice Chair of Global Health, Department of Radiology at Vanderbilt University Medical Center. "Wearable, operator-independent ultrasound technologies have the potential to dramatically improve access, speed, and accuracy, especially for women with dense breasts."

Business Wire
Jan 14th, 2026
iSono Health launches ATUSA, world's first wearable automated breast ultrasound, backed by $14.7M funding

iSono Health has launched ATUSA, the world's first FDA-cleared wearable, automated breast ultrasound platform, and is opening its Series A funding round during JPMorgan Healthcare Week. The company aims to address the $14 billion US breast imaging market by eliminating dependence on skilled sonographers and expensive equipment. ATUSA captures full 3D breast volumes in approximately two minutes per breast through automated scanning, roughly 10 times faster than manual ultrasound. The system enables primary care providers and OB/GYNs to offer specialist-level imaging directly in their offices through an "Ultrasound-as-a-Service" model. iSono Health has raised $14.7 million to date, including a recent $3 million seed round led by Draper Associates and Transform VC, plus $3.7 million in non-dilutive funding from NIH, NSF and NCI. The company is conducting the 800-patient AUDIBLE Study across leading medical institutions.

IT桔子
Oct 21st, 2025
iSono Health Secures $3M Seed Funding

iSono Health, a company providing 3D ultrasound imaging devices for breast cancer monitoring, has secured $3 million in seed funding. The device allows women to perform monthly breast checks at home without radiation, taking only two minutes per session.

Ain.ua
Oct 14th, 2025
About iSono Health

iSono Health will use the new funding to further develop its ATUSA automated 3D breast ultrasound system, expand clinical validation through NIH-funded studies, and scale its technology to make preventive breast exams faster, more accessible, and widely available globally.

Vestbee
Oct 14th, 2025
iSono Health secures $5M for breast screening

JSK Investments Group has funded US startup iSono Health, creator of the ATUSA™, a 3D breast ultrasound system. The funding round, led by JSK, will help iSono Health expand its system's reach, enhance AI image analysis, and support NIH-backed studies. iSono Health secured approximately $5 million in early 2025. The partnership aims to make breast screening more accessible globally.